US Bancorp’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Buy
347,651
+283
+0.1% +$18.6K 0.02% 300
2026
Q1
$24.7M Buy
347,368
+10,921
+3% +$861K 0.03% 280
2025
Q4
$27.6M Buy
336,447
+15,861
+5% +$1.24M 0.03% 274
2025
Q3
$24.1M Buy
320,586
+3,461
+1% +$258K 0.03% 301
2025
Q2
$23.5M Buy
317,125
+13,261
+4% +$923K 0.03% 292
2025
Q1
$24.5M Buy
303,864
+17,402
+6% +$1.5M 0.03% 286
2024
Q4
$22.4M Sell
286,462
-9,920
-3% -$843K 0.03% 297
2024
Q3
$27.8M Buy
296,382
+2,664
+0.9% +$224K 0.04% 271
2024
Q2
$22.9M Buy
293,718
+130,722
+80% +$10.7M 0.03% 279
2024
Q1
$14.8M Buy
162,996
+16,472
+11% +$1.37M 0.02% 353
2023
Q4
$11.3M Buy
146,524
+66,638
+83% +$4.67M 0.02% 398
2023
Q3
$5.44M Sell
79,886
-11,967
-13% -$871K 0.01% 529
2023
Q2
$7.46M Sell
91,853
-3,005
-3% -$240K 0.01% 469
2023
Q1
$7.78M Buy
+94,858
New +$6.77M 0.01% 459

Other funds holding GEHC

US Bancorp's GEHC Position: Q2 2026 in Review

US Bancorp increased its GE HealthCare (GEHC) stake by 0.08% in Q2 2026, buying an estimated $18.6K and bringing the position to 347,651 shares worth $22.3M. The position accounts for 0.02% of the portfolio, ranked #300.

US Bancorp first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $27.8M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • US Bancorp held 347,651 shares of GE HealthCare worth $22.3M as of Q2 2026.
  • US Bancorp bought 283 GE HealthCare shares in Q2 2026, an estimated $18.6K.
  • GE HealthCare made up 0.02% of US Bancorp's portfolio in Q2 2026, its #300 holding.
  • US Bancorp first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • US Bancorp's GE HealthCare position peaked at $27.8M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.